A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60‐year‐old acute myeloid leukemia patients with myelodysplasia syndrome features

In acute myeloid leukemia (AML), myelodysplasia‐related changes contribute to a poor prognosis. This retrospective, propensity score‐matched study analyzed 108 newly diagnosed AML patients with features of myelodysplasia syndrome (MDS) (aged 14‐60 years) from 2014 to 2018, who received either idarub...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fengqi, Wang, Hehua, Liu, Junru, Zhou, Zhenhai, Zheng, Dong, Huang, Beihui, Su, Chang, Zou, Waiyi, Xu, Duorong, Tong, Xiuzhen, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718585/
https://www.ncbi.nlm.nih.gov/pubmed/31322840
http://dx.doi.org/10.1002/cam4.2418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718585/
https://www.ncbi.nlm.nih.gov/pubmed/31322840
http://dx.doi.org/10.1002/cam4.2418

Ejemplares similares